Dr. Sandra Siegert, co-founder and Scientific Advisor at Syntropic Medical, is a trained biologist studying how microglia influence brain function. She received her Diplom at Johann Wolfgang Goethe University in Frankfurt/Main, Germany, in 2005 and her Ph.D. in Neurobiology at the Friedrich Miescher Institute for Biomedical Research (FMI) in Basel, Switzerland, in 2010 in vision processing in the retina. She was awarded an HFSP and SNSF fellowship to perform her postdoctoral work at MIT, where she revealed new insights into the underlying mechanisms causing schizophrenia. In 2015, she returned to Europe, joined ISTA as an independent Assistant Professor with an ERC starting grant, and received tenure in 2023. During the course of her career path, she has been involved in innovative technology development, which resulted in two patent applications, one with Novartis during her PhD and one at ISTA for the discovery of the 60-Hz reduces perineuronal nets, which lock the brain in a functional state. To explore the potential of this non-invasive light therapy as a treatment for mental health challenges and as an ERC PoC awardee, she co-founded the start-up Syntropic Medical GmbH in 2023.

• 

  Co-Founder and Scientific Advisor in Syntropic

  Syntropic develops novel new treatments for psychiatric disorders.